Sunday, November 5, 2017
- 9:00AM-11:00AM
-
Abstract Number: 635
Short-Term Efficacy and Safety of New Biological Agents Targeting the IL-6, IL-12/23 and IL-17 Pathways for Active Psoriatic Arthritis: A Network Meta-Analysis of Randomised Controlled Trials
Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster I- 9:00AM-11:00AM
-
Abstract Number: 366
Short-Term Outcomes in Patients with Systemic-Onset Juvenile Idiopathic Arthritis Treated with Either Tocilizumab or Anakinra in a Real-World Setting in the United Kingdom
Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster I: Autoinflammatory Disorders and Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 570
Signalling Pathways Identified in Salivary Glands from Primary Sjögren’s Syndrome Patients Reveal Enhanced Adipose Tissue Development, As Demonstrated By Microarray Analysis, Real-Time PCR and Immunohistochemistry
Sjögren's Syndrome Poster I: Translational Research- 9:00AM-11:00AM
-
Abstract Number: 26
Single B Cell Analysis Revealed the Relationship Among the Cytokine Profile, Antibody Affinity, and Pathogenic Roles of Autoantigen-Reactive B Cells in Systemic Sclerosis
B Cell Biology and Targets in Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 31
Single Cell Analysis Revealed That the Response to Cyclophosphamide Therapy Is Regulated By B Cells in Systemic Sclerosis-Associated Interstitial Lung Disease
B Cell Biology and Targets in Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 467
Smoking and Opioid Use Is Associated with Symptom Severity in Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response- 9:00AM-11:00AM
-
Abstract Number: 124
Smoking and Rheumatoid Arthritis Susceptibility; Quantification of the Impact of Cumulative Dose, Frequency and Duration of Smoking, and Smoking Cessation
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 786
Smoking As a Risk Factor for Giant Cell Arteritis: A Systematic Review and Meta-Analysis
Vasculitis Poster I: Large Vessel Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 126
Smoking Is Causally Associated with Disease Activity in Rheumatoid Arthritis
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 218
Social Factors and Racial Disparities in Total Hip Arthroplasty Outcomes
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 441
Social Media Based, Direct-to-Patient Study Designed for Development of “from Home” Testing for Rheumatoid Arthritis Patients Is Feasible and Engaged Individuals with Distinct Clinical Characteristics
Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response- 9:00AM-11:00AM
-
Abstract Number: 454
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Correlates with Disease Activity in Early Rheumatoid Arthritis and Reflects Joint Damage over Time
Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response- 9:00AM-11:00AM
-
Abstract Number: 677
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts the Development of Organ Damage over 5 Years in Systemic Lupus Erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 30
Specificity of Salivary Gland-Derived Monoclonal Antibodies from Sjogren’s Syndrome Patients Using Human Proteome Arrays